ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX · Real-Time Price · USD
1.720
-0.030 (-1.71%)
Feb 21, 2025, 4:00 PM EST - Market closed
ESSA Pharma Employees
ESSA Pharma had 35 employees as of September 30, 2024. The number of employees decreased by 15 or -30.00% compared to the previous year.
Employees
35
Change (1Y)
-15
Growth (1Y)
-30.00%
Revenue / Employee
n/a
Profits / Employee
-$888,869
Market Cap
76.35M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
EPIX News
- 6 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - Accesswire
- 11 days ago - ESSA Pharma Reports Financial Results for Fiscal First Quarter Ended December 31, 2024 - PRNewsWire
- 16 days ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit – EPIX - GlobeNewsWire
- 20 days ago - ESSA Pharma Inc. Is Being Sued For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm - Accesswire
- 23 days ago - Shareholders of ESSA Pharma Inc. Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - EPIX - PRNewsWire
- 24 days ago - DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewsWire
- 26 days ago - Rosen Law Firm Urges ESSA Pharma Inc. (NASDAQ: EPIX) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Business Wire
- 2 months ago - ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2024 - PRNewsWire